Glaxo plots £8bn move to buy back Beechams stake
Why GSK had to sell its Indian consumer health business
GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon | Fierce Pharma
GSK shares: Price analysis before buying or selling
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BWRRND7NK5ORFONQ4YXBCQPDTU.jpg "GSK raises $1.24 bln from latest Haleon stake sale | Reuters")
GSK raises $1.24 bln from latest Haleon stake sale | Reuters
The trading activity of the stock GSK between the 26500 − 28500'th... | Download Scientific Diagram
GSK Raises Almost £1 Billion by Selling Another Haleon Stake - Bloomberg
GSK Shares Gain on Analyst Upgrade, Price Target Boost - TipRanks.com
GSK bets on cough drug with $2bn deal for Canadian biotech
GSK To Sell Poznań Manufacturing Site To Delpharm | Contract Pharma
Is GSK a Strong Buy Right Now? | The Motley Fool
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK - MarketWatch
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
GSK plc (NYSE:GSK) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg
GSK plc - Wikipedia
GSK to sell 2.9% stake in former consumer healthcare business Haleon | Reuters
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners - Simply Wall St News
GSK plans to sell stake in Unilever's India unit: Report
Pfizer to sell stake in GSK consumer health joint venture after spinoff | HealthCare Middle East & Africa Magazine
A GSK Dividend Cut Is Imminent - Should I Sell GlaxoSmithKline? - TEV
